جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.
RZ

Raghad Mohammed Zayed

بانتظار توثيق الانتساب2026–2026
2وثائق Scopus
0استشهاداً
0مؤشر h
0منها بانتماء الجامعة
إجمالي Scopus (كل الجهات)
مقالوصول مغلق2026

Diagnostic Accuracy of Artificial Intelligence versus Clinical Diagnosis in Detecting Acute Otitis Media: A Systematic Review and Meta-analysis

Saudi Journal of Otorhinolaryngology Head and Neck Surgery

Abstract Acute otitis media (AOM) represents a prevalent infection in children globally, leading to considerable morbidity and imposing a substantial burden on healthcare systems. Prompt and precise diagnosis is critical to reducing complications, such as tympanic membrane perforation, hearing impairment, and excessive antibiotic prescribing. Advances in artificial intelligence (AI), particularly deep learning, have created opportunities to enhance diagnostic accuracy and broaden access to care, especially in low-resource settings. This systematic review and meta-analysis aimed to evaluate the diagnostic performance of AI-based systems for detecting AOM compared with conventional clinical diagnosis and to analyze their accuracy relative to human clinicians across different model architectures and diagnostic methods. Following PRISMA-DTA standards and PROSPERO registration, systematic searches were conducted in PubMed, Web of Science, and IEEE Xplore up to July 30, 2025. Eligible studies included human participants with suspected AOM, employed AI-driven diagnostic approaches, and used a clinical reference standard. The Quality Assessment of Diagnostic Accuracy Studies-2 tool assessed bias, and pooled sensitivity and specificity were estimated using a bivariate random-effects model. Nine studies published between 2020 and 2025 met the inclusion criteria. The pooled sensitivity and specificity were 91% (95% confidence interval [CI]: 77%–97%) and 99% (95% CI: 94%–100%), respectively. AI models overall matched or outperformed general practitioners and pediatricians, approaching otolaryngologist-level accuracy. AI-based tools have the potential to improve AOM detection, mitigate inequalities in healthcare access, and promote more effective diagnosis, particularly in underserved regions.

acute otitis mediaartificial intelligencedeep learningdiagnostic accuracy
مراجعةمفتوح (مستودع)2026

Early Versus Late Initiation of High-Efficacy Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Annals of Middle Eastern Medicine

Background: Relapsing-remitting multiple sclerosis is a chronic immune-mediated disorder of the central nervous system associated with recurrent inflammatory activity and long-term disability accumulation. Although escalation therapy has traditionally been used, early initiation of high-efficacy disease-modifying therapies may provide stronger inflammatory control and improve long-term outcomes. Objective: This systematic review and meta-analysis aimed to compare early initiation of high-efficacy disease-modifying therapies with escalation or delayed treatment strategies in adults with relapsing-remitting multiple sclerosis. Methods: PubMed, Scopus, and Web of Science were systematically searched. Eligible studies included adults with relapsing-remitting multiple sclerosis treated with either early high-efficacy disease-modifying therapies or escalation/delayed strategies. Outcomes included annualized relapse rate, Expanded Disability Status Scale change, and delta-Expanded Disability Status Scale. Study quality was assessed using the Newcastle-Ottawa Scale, and pooled analyses were performed using random-effects models. Results: Ten observational cohort studies were included. Early initiation of high-efficacy treatment was associated with lower annualized relapse rate than escalation therapy. Disability findings remained uncertain. The pooled EDSS-change analysis was not statistically significant and showed considerable heterogeneity. Only one eligible study reported an adjusted delta-EDSS comparison; therefore, this outcome was reported narratively and was not meta-analyzed. Nonrandom treatment allocation and potential confounding by indication limit causal interpretation. Conclusion: Early initiation of high-efficacy disease-modifying therapy was associated with lower relapse activity in observational RRMS cohorts. The available disability evidence does not establish a causal advantage of either treatment strategy and requires cautious interpretation.

relapsing-remitting multiple sclerosisdisease-modifying therapyearly treatment initiationtreatment delay